CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Capstone Therapeutics Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Capstone Therapeutics Corp
SUITE 101, 1275 WEST WASHINGTON STREET
Phone: (602) 286-5520p:602 286-5520 TEMPE, AZ  85281  United States Ticker: CAPSCAPS
This company ceased filing statements with the SEC on 9/25/2019.
Business Summary
Capstone Therapeutics Corp., formerly Capstone Holding Corp., operates, through its wholly owned subsidiary, TotalStone, LLC, which is a construction materials company. TotalStone, LLC distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States. The Company, through its subsidiary, Capstone Beta, LLC, owns an equity interest in Diamond Products, LLC, which is a sexual wellness products holding company. Diamond Products, LLC product portfolio includes adult toys, lingerie, games, lotions and creams that are sold globally in over 80 countries through 5,000 retailers, as well as e-commerce Websites.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201912/31/2019YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer, Vice President, Treasurer EdwardSchultz 8/25/2023 8/25/2023
Consultant Randolph C.Steer 73 10/31/2011 4/5/2006
Lead Independent Director John M.Holliman 69 12/29/2023 8/1/1997
Director Matthew E.Lipman 44 7/14/2017 7/14/2017
Director Michael E.Toporek 58 7/14/2017 7/14/2017

Business Names
Business Name
CAPS
CAPSD
OrthoLogic Corporation

General Information
Number of Employees: 2 (As of 12/31/2012)
Outstanding Shares: 157,610 (As of 3/31/2024)
Shareholders: 805
Stock Exchange: OTC
Federal Tax Id: 860585310
Fax Number: (302) 655-5049
Email Address: webmaster@olgc.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 26, 2024